certus molecular diagnostics

Zollikofen, Switzerland Founded: 2017 • Age: 9 yrs
Rapid tests for detecting specific microorganism genes are provided.
Request Access

About certus molecular diagnostics

certus molecular diagnostics is a company based in Zollikofen (Switzerland) founded in 2017.. certus molecular diagnostics offers products and services including Molecular Rapid Tests. certus molecular diagnostics operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.

  • Headquarter Zollikofen, Switzerland
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Certus Molecular Diagnostics Ag
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of certus molecular diagnostics

certus molecular diagnostics offers a comprehensive portfolio of products and services, including Molecular Rapid Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Rapid tests for detecting pathogens with 30-minute results and simple use.

Funding Insights of certus molecular diagnostics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by certus molecular diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - certus molecular diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Certus Molecular Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of certus molecular diagnostics

certus molecular diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of diagnostic solutions for systemic infections
domain founded_year HQ Location
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
domain founded_year HQ Location
Provider of machine learning based diagnostic solutions for infectious diseases
domain founded_year HQ Location
Portable PCR diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Instruments and test panels for multiplexed molecular diagnostics are provided.
domain founded_year HQ Location
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Certus Molecular Diagnostics

Frequently Asked Questions about certus molecular diagnostics

When was certus molecular diagnostics founded?

certus molecular diagnostics was founded in 2017.

Where is certus molecular diagnostics located?

certus molecular diagnostics is headquartered in Zollikofen, Switzerland. It is registered at Zollikofen, Bern, Switzerland.

What does certus molecular diagnostics do?

Certus Molecular Diagnostics was founded in 2017 and is based in Zollikofen, Switzerland. Operations focus on the molecular diagnostics sector, where rapid tests for identifying specific genes in microorganisms are developed and supplied. A proprietary isothermal amplification method combined with real-time detection is utilized. Ready-to-use reagents are offered, enabling targeted gene segments to be amplified isothermally and detected via a dsDNA-intercalating dye.

Who are the top competitors of certus molecular diagnostics?

certus molecular diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.

What products or services does certus molecular diagnostics offer?

certus molecular diagnostics offers Molecular Rapid Tests.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available